Table 1 Mature cell output (×10 3 ) of... | American Society of Hematology

Table 1

Mature cell output (×10³) of clones serially repopulating 1 primary and 2 secondary recipients

	Week	Clone 110			Clone 96			Clone 65			Clone 99
	Week	M	B	T	M	B	T	M	B	T	M	B	T
Primary recipient	4	—	—	—	—	—	—	—	—	—	—	—	—
	9	—	—	—	23	—	—	32	121	—	—	—	—
	16	78	—	—	198	792	—	122	618	—	242	335	—
	27	511	364	13	318	239	87	113	759	—	117	—	—
Secondary recipients	4	18/42	^−/−	^−/−	31/-	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	8	23/5	23/-	^−/−	0.3/-	-/19	^−/−	^−/−	2/-	^−/−	^−/−	12/-	^−/−
	12	-/10	481/-	^−/−	-/62	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	16	123/68	517/-	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	20	-/36	-/50	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	24	39/-	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	Week	Clone 94			Clone 98			Clone 113
	Week	M	B	T	M	B	T	M	B	T
Primary recipient	4	—	—	—	—	—	—	—	—	—
	9	—	1	—	—	—	—	—	—	—
	16	—	—	—	173	1372	—	—	—	—
	27	—	—	—	236	788	—	—	20	38
Secondary recipients	4	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	8	^−/−	1/-	^−/−	^−/−	5/4	^−/−	^−/−	2/6	^−/−
	12	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	16	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	20	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	24	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−

	Week	Clone 110			Clone 96			Clone 65			Clone 99
	Week	M	B	T	M	B	T	M	B	T	M	B	T
Primary recipient	4	—	—	—	—	—	—	—	—	—	—	—	—
	9	—	—	—	23	—	—	32	121	—	—	—	—
	16	78	—	—	198	792	—	122	618	—	242	335	—
	27	511	364	13	318	239	87	113	759	—	117	—	—
Secondary recipients	4	18/42	^−/−	^−/−	31/-	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	8	23/5	23/-	^−/−	0.3/-	-/19	^−/−	^−/−	2/-	^−/−	^−/−	12/-	^−/−
	12	-/10	481/-	^−/−	-/62	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	16	123/68	517/-	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	20	-/36	-/50	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	24	39/-	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	Week	Clone 94			Clone 98			Clone 113
	Week	M	B	T	M	B	T	M	B	T
Primary recipient	4	—	—	—	—	—	—	—	—	—
	9	—	1	—	—	—	—	—	—	—
	16	—	—	—	173	1372	—	—	—	—
	27	—	—	—	236	788	—	—	20	38
Secondary recipients	4	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	8	^−/−	1/-	^−/−	^−/−	5/4	^−/−	^−/−	2/6	^−/−
	12	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	16	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	20	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−
	24	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−	^−/−

B, B cells; M, myeloid; T, T cells; —, no detectable output.